Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system

Cancer Letters

Volumn 270, Issue 2, 2008, Pages 295-301

  Nakagawa, Hiroaki ^a   Ohira, Miki ^b   Hayashi, Shunji ^b   Abe, Shigeaki ^a   Saito, Shin ^a   Nagahori, Noriko ^a   Monde, Kenji ^a   Shinohara, Yasuro ^a   Fujitani, Naoki ^a   Kondo, Hirosato ^c   Akiyama, Shin Ichi ^d   Nakagawara, Akira ^b   Nishimura, Shin Ichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cisplatin; Gene expression profile; N glycan profile; resistant revertant cell

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; GLYCAN DERIVATIVE; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MANNOSE; OLIGOSACCHARIDE;

ARTICLE; CANCER CELL CULTURE; CARBOHYDRATE SYNTHESIS; CARCINOMA; CARCINOMA CELL; COMPLEX FORMATION; CULTURE MEDIUM; DNA MICROARRAY; DRUG SENSITIVITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HLA ANTIGENS; HUMANS; LYSOSOMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYSACCHARIDES; PROTEIN TRANSPORT;

EID: 52149093871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.019     Document Type: Article

References (27)

1. Loehrer P.J., and Einhorn L.H. Cisplatin. Ann. Int. Med. 100 (1984) 704-713
2. Kartalou M., and Essigmann J.M. Mechanisms of resistance to cisplatin. Mutation Res. 478 (2001) 23-43
3. Ishikawa T., and Ali-Osman F. Glutathione-saaociated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem. 268 (1993) 20116-20125
4. Akervall J., Guo X., Qian C.-N., Schoumans J., Leeser B., Kort E., Cole A., Resau J., Bradford C., Carey T., Wennerberg J., Anderson H., Tennvall J., and Teh B.T. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell line and patients. Clin. Cancer Res. 10 (2004) 8204-8213
5. Castagna A., Antonioli P., Astner H., Hamdan M., Righetti S.C., Perego P., Zunino F., and Righetti P.G. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 4 (2004) 3246-3267
6. Fujii R.-I., Mutoh M., Niwa K., Yamada K., Aikou T., Nakagawa M., Kuwano M., and Akiyama S. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn. J. Cancer Res. 85 (1994) 426-433
7. Fujii R.-I., Mutho M., Sumizawa T., Chen Z., Yoshimura A., and Akiyama S. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J. Nat. Cancer I 86 (1994) 1781-1784
8. Chen Z.-S., Sumizawa T., Furukawa T., Ono K., Tani A., Komatzu M., and Akiyama S.-I. An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells. Cancer Lett. 138 (1999) 13-22
9. Hayashi S., Ozaki T., Yoshida K., Hosoda M., Todo S., Akiyama S.-I., and Nakagawara A. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53. Biochem. Biophys. Res. Commun. 347 (2006) 60-66
10. Hakomori S.-I. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56 (1996) 5309-5318
11. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3 (1993) 97-130
12. Noda I., Fujieda S., Seki M., Tanaka N., Sunaga H., Ohtsubo T., Tsuzuki H., Fan G.-K., and Saito H. Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells. Int. J. Cancer 80 (1999) 279-284
13. Kudo T., Nakagawa H., Takahashi M., Hamaguchi J., Kamiyama N., Yokoo H., Nakanishi K., Nakagawa T., Kamiyama T., Deguchi K., Nishimura S.-I., and Todo S. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol. Cancer 6 (2007) 32
14. Nakahara S., Miyoshi E., Noda K., Ihara S., Gu J., Honke K., Inohara H., Kubo T., and Taniguchi N. Involvement of oligosaccharide changes in α5β1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol. Cancer Ther. 2 (2003) 1207-1214
15. Hase S., Ikenaka T., and Matsushima Y. Structure analyses of oligosaccharides by tagging of the reducing end sugars with a fluorescent compound. Biochem. Biophys. Res. Commun. 85 (1978) 257-263
16. Yamamoto S., Hase S., Fukuda S., Sano O., and Ikenaka T. Structures of the sugar chains interferon-c produced by human myelomocyte cell line HBL-38. J. Biochem. 105 (1989) 547-555
17. Takahashi N., and Tomiya N. Analysis of N-linked oligosaccharides: application of glycoamidase A. In: Takahashi N., and Muramatsu T. (Eds). Handbook of Endoglycosidases and Glycoamidases (1992), CRC Press, Boca Raton, FL 199-332
18. Ohira M., Oba S., Nakamura Y., Isogai E., Kaneko S., Nakagawa A., Hirata T., Kubo H., Goto T., Yamada S., Yoshida Y., Fuchioka M., Ishii S., and Nakagawara A. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell 7 (2005) 337-350
19. Yoshikawa T., Nagasugi Y., Azuma T., Kato M., Sugano S., Hashimoto K., Masuho Y., Muramatsu M., and Seki N. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem. Biophys. Res. Commun. 275 (2000) 532-537
20. 1. Cancer Res. 62 (2002) 2203-2209
21. Cleaveland W.S. Robust locally weighted regression and smoothing scatter plots. J. Am. Stat. Assoc. 74 (1979) 829-836
22. Okazaki A., Shoji-Hosaka E., Nakamura K., Wakitani M., Uchida K., Kakita S., Tsumoto K., Kumagai I., and Shitara K. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa. J. Mol. Biol. 336 (2004) 1239-1249
23. Nakagawa T., Uozumi N., Nakano M., Mizuno-Horikawa Y., Okuyama N., Taguchi T., Gu J., Kondo A., Taniguchi N., and Miyoshi E. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. J. Biol. Chem. (2006) 29797-29806
24. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Ann. Rev. Biochem. 54 (1985) 631-664
25. Helenius A., and Abei M. Intracellular functions of N-linked glycans. Science 291 (2001) 2364-2369
26. Honey K., and Rudensky A.Y. Lysosomal cystein proteases regulate antigen presentation. Nat. Rev. Immunol. 3 (2003) 472-482
27. Kikuchi H., Ozaki T., Furuya K., Hanamoto T., Nakanishi M., Yamamoto H., Yoshida K., Todo S., and Nakagawara A. NF-κB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteosome pathway. Oncogene 25 (2006) 7608-7617